Contact TB-500 Compound
A wrong molecule or an overstated outcome can change the whole argument. Corrections are welcome.
Article corrections
If TB-500 Compound has attributed a result to the fragment when the experiment used full-length thymosin beta-4, please identify the article and the sentence. A study title or identifier, plus the specific outcome at issue, makes a correction much easier to assess.
Mislabeled rat dose groups, a modeled optimum presented as a tested amount, or an incorrect date on an FDA entry would each merit a correction. Those details carry much of the argument here. A correction that changes the conclusion is especially useful.
Scope of inquiries
This contact channel is for the articles and their sources. Please omit health histories, requests for a dose and questions about obtaining a substance. Personal medical questions require a licensed healthcare professional who can evaluate the situation. The reading list may help with a source query; legal status contains the FDA and sports discussion.